Best Herbs for Sleep: What Human Evidence Supports in 2026
By Will
Evidence-first guide to ashwagandha, passionflower, valerian, chamomile, and lavender-related sleep evidence, with directness, safety limits, and chronic-insomnia guidance.
Bottom line
There is no evidence-based “first herb” for every sleep problem
Ashwagandha has a small pooled sleep signal from five placebo-controlled trials, but the evidence is preparation-specific and multi-week. Passionflower now has two small randomized signals using specific extracts: the existing 110-person DSM-5 insomnia trial and a newer 65-person stress-and-insomnia trial. The newer study is product-specific and includes authors affiliated with the botanical company, so neither trial supports a same-night winner rule or broad class-wide efficacy.
Valerian and chamomile remain weaker than their popularity suggests. A 2024 valerian umbrella review found no evidence of efficacy for treating insomnia. A newer chamomile meta-analysis found a pooled sleep-quality signal, but heterogeneity was very high (I² 88.4%) and sleep duration, sleep efficiency, and daytime functioning did not consistently improve. Lavender-related aromatherapy research is a different intervention from taking an oral lavender supplement.
This table scrolls horizontally on small screens. Use Tab to focus the table region, then scroll with arrow keys or touch.
| Option | Direct human sleep evidence | Main limit | Interpretation |
|---|---|---|---|
| Ashwagandha | 2021 meta-analysis: 5 placebo-controlled RCTs / 400 adults using specific standardized extracts over repeated multi-week regimens. | Small pooled effect, moderate heterogeneity, preparation-specific evidence, and limited long-term safety data. | Limited sleep signal. |
| Passionflower | Two small randomized trials using specific passionflower extracts: 110 adults with DSM-5 insomnia for 2 weeks, plus 65 participants with stress and insomnia in a 30-day standardized-extract trial. | Product-specific evidence remains preliminary; several outcomes were null in the 2020 trial, and two authors in the 2024 study listed affiliations with JK Botanicals. | Preliminary. |
| Valerian | 2024 umbrella review included 8 systematic reviews and found some subjective sleep-quality signals. | No evidence of efficacy for treating insomnia; primary studies were heterogeneous and generally low quality. | Not established for insomnia. |
| Chamomile | 2024 meta-analysis: 10 studies / 772 participants; pooled PSQI scores favored chamomile. | Heterogeneity was very high (I² 88.4%); sleep duration, sleep efficiency, and daytime-function findings did not consistently improve, and there is still no conclusive clinical-trial evidence that chamomile helps insomnia. | Inconclusive. |
| Lavender / aromatherapy | Aromatherapy reviews report possible sleep-quality improvements across heterogeneous essential-oil studies. | Aromatherapy evidence does not establish that oral lavender products treat insomnia; interventions and populations vary. | Indirect for an oral-herb claim. |
How to read this comparison: direct human sleep outcomes carry more weight than mechanisms, traditional use, or popularity. Preparation match, population, duration, outcome type, study quality, and heterogeneity can all limit how far a result should generalize. Read the evidence methodology →
Evidence Snapshot
Evidence: LimitedAshwagandha
- Human evidence
- Five placebo-controlled randomized trials / 400 adults were pooled in the 2021 sleep meta-analysis. Trials used defined standardized extracts and repeated dosing over weeks rather than an as-needed bedtime rescue strategy.
- Research signal
- Stress and neuroendocrine hypotheses may help explain research questions, but symptoms do not diagnose a cortisol problem or identify who should use ashwagandha.
- Safety profile
- NCCIH notes uncertain long-term safety, rare liver injury, pregnancy/breastfeeding avoidance, thyroid and autoimmune cautions, surgery concerns, and medication interactions.
Evidence Snapshot
Evidence: LimitedPassionflower
- Human evidence
- Two small randomized trials provide product-specific signals. A 110-person DSM-5 insomnia trial found a two-week total-sleep-time benefit while several other outcomes did not differ; a 2024 trial in 65 participants with stress and insomnia reported a 30-day total-sleep-time signal with a standardized extract. Two authors in the newer study listed affiliations with JK Botanicals.
- Research signal
- Sedative or GABA-related mechanisms are hypotheses; they do not establish clinical insomnia efficacy or justify combining passionflower with other sedating products.
- Safety profile
- NCCIH lists drowsiness, dizziness, and confusion; pregnancy and perioperative cautions apply because of uterine and nervous-system concerns.
Evidence Snapshot
Evidence: LimitedValerian
- Human evidence
- The 2024 umbrella review found no evidence of efficacy for treating insomnia, despite some subjective sleep-quality signals across prior reviews.
- Research signal
- Traditional sedative use and proposed GABA-related effects do not overcome heterogeneous, low-quality clinical evidence.
- Safety profile
- Long-term safety remains uncertain. Adding valerian to alcohol, sedatives, or multiple calming products can increase complexity and potential sedation risk.
Evidence Snapshot
Evidence: LimitedChamomile
- Human evidence
- A 2024 meta-analysis included 10 studies / 772 participants and found a pooled PSQI improvement, but heterogeneity was very high (I² 88.4%). Sleep duration, sleep efficiency, and daytime-function findings did not consistently improve, so this does not establish chamomile as an insomnia treatment.
- Research signal
- Apigenin-related receptor hypotheses are not equivalent to demonstrated insomnia treatment efficacy.
- Safety profile
- Chamomile can trigger allergic reactions, especially in people sensitive to ragweed or related plants. A 2025 systematic safety review also found insufficient pregnancy and lactation safety data; product form and dose vary substantially.
Why magnesium and L-theanine are not ranked as “herbs” here
Magnesium is a mineral and L-theanine is an amino acid. Both belong in the broader sleep-supplement comparison, where their evidence can be judged without making a botanical ranking look stronger by mixing unlike categories.
Best sleep supplements evidence guide →Separate herb studies do not validate a sleep stack
Evidence for individual ingredients does not prove that valerian + passionflower, magnesium + ashwagandha, or any other combination is synergistic, faster, or safer. Combining several sedating products also makes benefit, side effects, and interactions harder to attribute.
Sleep stack evidence guide →Check before using
Safety and stop rules
- Ashwagandha: avoid during pregnancy/breastfeeding and review thyroid, autoimmune, liver, surgery, and medication issues before use.
- Passionflower: may cause drowsiness, dizziness, or confusion; avoid during pregnancy and discuss perioperative use because of anesthesia interactions.
- Chamomile: allergy risk is higher in people sensitive to ragweed or related plants; a 2025 systematic review found pregnancy and lactation safety data insufficient.
- Valerian and other sedating herbs: long-term safety is uncertain; stacking sedating products increases complexity and may increase impairment.
- Persistent symptoms: loud snoring/gasping, dangerous daytime sleepiness, restless-legs symptoms, severe mood symptoms, or chronic insomnia warrant evaluation rather than escalating herbs.
Chronic insomnia has a stronger first-line treatment
AASM describes cognitive behavioral therapy for insomnia (CBT-I) as the first-line, evidence-based treatment for chronic insomnia. A botanical comparison should not make supplements look equivalent to that evidence base.
Persistent poor sleep can also reflect sleep apnea, restless legs, circadian disorders, medication effects, mood disorders, substance use, pain, or insufficient sleep opportunity.
Product sourcing note
This broad guide intentionally does not rank affiliate products. Study extracts, teas, essential oils, and retail capsules are not automatically interchangeable. Ingredient-specific evidence pages are the better place to evaluate plant part, extract, preparation, standardization, and independent quality testing.
Frequently asked questions
What is the best herb for sleep?
Current evidence does not support one universal winner. Ashwagandha has a small multi-trial sleep signal from specific standardized extracts. Passionflower has a preliminary two-week insomnia trial. Valerian and chamomile should not be presented as established insomnia treatments, and lavender aromatherapy evidence does not establish that oral lavender products treat insomnia.
Which sleep herb works fastest?
The evidence reviewed here does not establish a reliable same-night winner. Ashwagandha trials generally used repeated dosing over weeks, the passionflower trials studied two- to four-week periods rather than same-night rescue use, and valerian/chamomile evidence is too inconsistent to support a dependable onset promise.
Does valerian work for insomnia?
A 2024 umbrella review found no evidence of efficacy for treating insomnia, despite some subjective sleep-quality signals. The underlying studies were heterogeneous and generally low quality.
Does passionflower help insomnia?
Two small randomized trials using specific passionflower extracts now provide preliminary signals. A 110-person DSM-5 insomnia trial found greater total sleep time after two weeks while several other outcomes did not differ; a newer 65-person stress-and-insomnia trial reported a 30-day total-sleep-time signal with a standardized extract. The newer study was product-specific and included authors affiliated with JK Botanicals, so these findings do not establish broad passionflower efficacy.
Can sleep herbs be combined?
Separate ingredient studies do not prove that a combination is more effective or safer. Combining sedating products can also make side effects and interactions harder to predict and makes it difficult to identify which ingredient caused benefit or harm.
What should I do if insomnia is chronic?
CBT-I is the first-line evidence-based treatment for chronic insomnia. Persistent sleep problems also warrant evaluation for causes such as sleep apnea, restless legs, circadian disorders, medication effects, mood disorders, substance use, pain, or insufficient sleep opportunity.
Sources and directness notes
- 1. NCCIH: Sleep disorders and complementary health approaches — Current overview of complementary sleep approaches. NCCIH says chamomile evidence is not conclusive, valerian trials are inconsistent and its insomnia value has not been demonstrated, and CBT-I remains the most strongly recommended treatment for insomnia.
- 2. Ashwagandha sleep systematic review and meta-analysis (2021) — Five placebo-controlled randomized trials / 400 adults. The pooled sleep effect was small with moderate heterogeneity. Trials used specific standardized extracts, populations, and multi-week regimens rather than a generic as-needed herb protocol.
- 3. Valerian insomnia umbrella review (2024) — Eight systematic reviews were included. The review found no evidence of efficacy for treating insomnia, although some subjective sleep-quality signals appeared; the underlying evidence was heterogeneous and low quality.
- 4. Passionflower insomnia randomized placebo-controlled trial (2020) — One hundred ten adults with DSM-5 insomnia disorder received passionflower extract or placebo for two weeks. Total sleep time improved versus placebo, while sleep efficiency and wake-after-sleep-onset did not differ significantly between groups.
- 5. NCCIH: Passionflower usefulness and safety — NCCIH describes the sleep research as small and mixed. Possible adverse effects include drowsiness, dizziness, and confusion; pregnancy and perioperative cautions apply.
- 6. Chamomile systematic review and meta-analysis (2019) — Review of randomized and quasi-randomized trials across anxiety, sleep quality, and insomnia outcomes. NCCIH still concludes that clinical evidence is not conclusive for insomnia.
- 7. Chamomile sleep systematic review and meta-analysis (2024) — Ten studies / 772 participants. The pooled PSQI signal favored chamomile, but heterogeneity was very high (I² 88.4%). Sleep duration, sleep efficiency, and daytime-function outcomes were not consistently improved, and objective sleep evidence remained limited.
- 8. Standardized passionflower extract randomized trial (2024) — Sixty-five participants with stress and insomnia were randomized to a standardized Passiflora incarnata extract or placebo for 30 days. Total sleep time improved, but the study was small and product-specific; two authors listed affiliations with JK Botanicals.
- 9. Chamomile adverse-events systematic review (2025) — Across 72 trials and 11 case reports, most reported adverse events were minor, while published case reports included allergic reactions. The review found insufficient safety data for pregnancy and lactation.
- 10. NCCIH: Ashwagandha usefulness and safety — Some preparations may help insomnia or stress, but long-term safety is not established. Pregnancy/breastfeeding, thyroid, autoimmune, liver, surgery, and medication-interaction cautions apply.
- 11. AASM: cognitive behavioral therapy for insomnia — The American Academy of Sleep Medicine describes CBT-I as the first-line, evidence-based treatment for chronic insomnia.
Free safety checklist
Get future sleep research notes by email
Evidence-first supplement updates, safety context, and new guide announcements. No universal herb rankings or bedtime protocols.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Newsletter
Continue with the newsletter archive
Short notes built for cautious supplement decisions.